Sirpa Jalkanen - Curriculum Vitae#

CV

Born: 1954
Place of Birth: Jyväskylä, Finland
Degrees: Faculty of Medicine, Turku University; Degrees received: M.D. 1979, Ph.D. 1983, Docent in Immunobiology 1987
Other training: Speciality in Clinical Microbiology 1990

Administration/leadership:

• Director of the MediCity Research Laboratory (Research Unit of the Medical Faculty of Turku University consisting 22 research groups) 1996-
  
• Director of one of the research profiling programs of BioCity Turku and the Faculty of Medicine, University of Turku, Receptor Program 1996-
  
• Director of the National Center of Excellence in Host Defence 2008-2013; partner in the National Center of Excellence in Translational Cancer Biology 2014-2019
  
• Vice Dean of the Medical Faculty, University of Turku 2010-
  

Training/education:

Theses supervised or co-supervised: 1. Palojoki Eeva 3/1995 2. Hänninen Arno 5/1995 3. Salmi Marko 5/1995 4. Aho Riitta 11/1995 5. Ristamäki Raija 12/1995 6. Airas Laura 6/1996 7. Wuorela Maarit 10/1996 8. Arvilommi (Kujari) Anna-Maija 5/1998 9. Bono Petri 10/1998 10. Jaakkola Kimmo 1/ 2000 11. Tohka Sami 10/2001 12. Henttinen Tiina 11/2001 13. Irjala Heikki 12/2002 14. Jaakkola Ilkka 5/2003 15. Maula Sanna 12/2003 16. Kurkijärvi Riikka 11/2004 17. Niemelä Jussi 3/2006 18. Kiss Jan 10/2008 19. Auvinen Kaisa 02/2009, 20. Laurila Juha 10/2010, 21. Autio Anu 03/2012, 22. Ålgars Annika 04/2012, 23. Karikoski Marika 11/2012, 24. Keuschnigg Johannes 6/2013

Postdoctoral training: I have trained 21 postdoctoral fellows. Many of them are in leading positions in industry or academia. Five of them can be considered very successful in their research holding full or adjunct professorships or Department head positions. Based on these educational achievements I have obtained a major prize in Finland, Maud Kuistila Prize.

Teaching: Immunology teaching since 1981 to medical students

Scientific impact:

Over 120 invited talks at international scientific meetings, over 10 patents or patent applications, 242 publications (PubMed), with H index 55 (Jalkanen S and Jalkanen ST, ISI Web of Knowledge), >10800 citations, 10 most cited ones are original articles (with 179-593 citations) except one, which is a review (cited 274 times), organizer or co-organizer of several international scientific meetings (for example 2 ESF (European Science Foundation) workshops, 2 Scandinavian Society for Immunology meetings, World Congress of Immunology, European Congress of Immunology, Keystone Meeting)

Societal impact:

I have made several discoveries with my group. They have led to founding of two biotech companies (BioTie Therapies, now publicly traded and Faron Pharmaceuticals). I am co-founder in both of them and they are exploiting my discoveries in clinical trials and at least so far very successfully.